Literature DB >> 29879856

Smoking cessation after engagement in HIV care in rural Uganda.

Julian A Mitton1,2, Crystal M North1,2,3, Daniel Muyanja4, Samson Okello4,5,6, Dagmar Vořechovská7, Bernard Kakuhikire8, Alexander C Tsai7,9,10, Mark J Siedner1,2,4,7.   

Abstract

People living with HIV (PLWH) are more likely to smoke compared to HIV-uninfected counterparts, but little is known about smoking behaviors in sub-Saharan Africa. To address this gap in knowledge, we characterized smoking cessation patterns among people living with HIV (PLWH) compared to HIV-uninfected individuals in rural Uganda. PLWH were at least 40 years of age and on antiretroviral therapy for at least three years, and HIV-uninfected individuals were recruited from the clinical catchment area. Our primary outcome of interest was smoking cessation, which was assessed using an adapted WHO STEPS smoking questionnaire. We fit Cox proportional hazards models to compare time to smoking cessation between PLWH pre-care, PLWH in care, and HIV-uninfected individuals. We found that, compared to HIV-uninfected individuals, PLWH in care were less likely to have ever smoked (40% vs. 49%, p = 0.04). The combined sample of 267 ever-smokers had a median age of 56 (IQR 49-68), 56% (n = 150) were male, and 26% (n = 70) were current smokers. In time-to-event analyses, HIV-uninfected individuals and PLWH prior to clinic enrollment ceased smoking at similar rates (HR 0.8, 95% CI 0.5-1.2). However, after enrolling in HIV care, PLWH had a hazard of smoking cessation over twice that of HIV-uninfected individuals and three times that of PLWH prior to enrollment (HR 2.4, 95% CI 1.3-4.6, p = 0.005 and HR 3.0, 95% CI 1.6-5.5, p = 0.001, respectively). In summary, we observed high rates of smoking cessation among PLWH after engagement in HIV care in rural Uganda. While we hypothesize that greater access to primary care services and health counseling might contribute, future studies should better investigate the mechanism of this association.

Entities:  

Keywords:  Africa; primary care; tobacco

Mesh:

Year:  2018        PMID: 29879856      PMCID: PMC6258063          DOI: 10.1080/09540121.2018.1484070

Source DB:  PubMed          Journal:  AIDS Care        ISSN: 0954-0121


  47 in total

1.  A cross-sectional study comparing the motivation for smoking cessation in apparently healthy patients who smoke to those who smoke and have ischaemic heart disease, hypertension or diabetes.

Authors:  S Wilkes; A Evans
Journal:  Fam Pract       Date:  1999-12       Impact factor: 2.267

2.  Leveraging the lessons learned from HIV/AIDS for coordinated chronic care delivery in resource-poor settings.

Authors:  Neil Gupta; Gene Bukhman
Journal:  Healthc (Amst)       Date:  2015-10-26

3.  Factors associated with successful smoking cessation in the United States, 2000.

Authors:  Chung-won Lee; Jennifer Kahende
Journal:  Am J Public Health       Date:  2007-06-28       Impact factor: 9.308

4.  Positive smoking cessation-related interactions with HIV care providers increase the likelihood of interest in cessation among HIV-positive cigarette smokers.

Authors:  Lauren R Pacek; Olga Rass; Matthew W Johnson
Journal:  AIDS Care       Date:  2017-05-23

Review 5.  Cigarette smoking in the HIV-infected population.

Authors:  Shiva Rahmanian; Mary Ellen Wewers; Susan Koletar; Nancy Reynolds; Amy Ferketich; Philip Diaz
Journal:  Proc Am Thorac Soc       Date:  2011-06

6.  Cigarette smoking and the desire to quit among individuals living with HIV.

Authors:  Edward M Mamary; Darlene Bahrs; Sharon Martinez
Journal:  AIDS Patient Care STDS       Date:  2002-01       Impact factor: 5.078

7.  Impact of cigarette smoking on mortality in HIV-positive and HIV-negative veterans.

Authors:  Kristina Crothers; Joseph L Goulet; Maria C Rodriguez-Barradas; Cynthia L Gibert; Kris Ann K Oursler; Matthew Bidwell Goetz; Stephen Crystal; David A Leaf; Adeel A Butt; R Scott Braithwaite; Robin Peck; Amy C Justice
Journal:  AIDS Educ Prev       Date:  2009-06

8.  Physicians are a key to encouraging cessation of smoking among people living with HIV/AIDS: a cross-sectional study in the Kathmandu Valley, Nepal.

Authors:  Rachel M Amiya; Krishna C Poudel; Kalpana Poudel-Tandukar; Jun Kobayashi; Basu D Pandey; Masamine Jimba
Journal:  BMC Public Health       Date:  2011-08-31       Impact factor: 3.295

9.  Tobacco use among people living with HIV: analysis of data from Demographic and Health Surveys from 28 low-income and middle-income countries.

Authors:  Noreen D Mdege; Sarwat Shah; Olalekan A Ayo-Yusuf; James Hakim; Kamran Siddiqi
Journal:  Lancet Glob Health       Date:  2017-06       Impact factor: 26.763

10.  Tobacco use and associated factors among Adults in Uganda: Findings from a nationwide survey.

Authors:  Steven Ndugwa Kabwama; Sheila Ndyanabangi; Gerald Mutungi; Ronald Wesonga; Silver K Bahendeka; David Guwatudde
Journal:  Tob Induc Dis       Date:  2016-08-11       Impact factor: 2.600

View more
  3 in total

1.  Tobacco Use among HIV-Positive and HIV-Negative Women and Men in Zambia-Demographic and Health Survey, 2018.

Authors:  Alissa C Kress; Carlen Stadnik; Masauso Moses Phiri; Fastone M Goma; Evelyn Twentyman
Journal:  Int J Environ Res Public Health       Date:  2022-03-24       Impact factor: 3.390

Review 2.  Roll-out of HIV pre-exposure prophylaxis: a gateway to mental health promotion.

Authors:  Daniel J Ikeda; Khameer Kidia; Bruce D Agins; Jessica E Haberer; Alexander C Tsai
Journal:  BMJ Glob Health       Date:  2021-12

3.  Treated HIV Infection and Progression of Carotid Atherosclerosis in Rural Uganda: A Prospective Observational Cohort Study.

Authors:  Mark J Siedner; Prossy Bibangambah; June-Ho Kim; Alexander Lankowski; Jonathan L Chang; Isabelle T Yang; Douglas S Kwon; Crystal M North; Virginia A Triant; Christopher Longenecker; Brian Ghoshhajra; Robert N Peck; Ruth N Sentongo; Rebecca Gilbert; Bernard Kakuhikire; Yap Boum; Jessica E Haberer; Jeffrey N Martin; Russell Tracy; Peter W Hunt; David R Bangsberg; Alexander C Tsai; Linda C Hemphill; Samson Okello
Journal:  J Am Heart Assoc       Date:  2021-06-05       Impact factor: 6.106

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.